APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Immunoglobulin for Intravenous Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Immunoglobulin for Intravenous Injection Market Analysis and Forecast 2026-2032

1 January 2026193 pages

Choose your research edition.

Industry ResearchHuman Immunoglobulin for Intravenous Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immunoglobulin for Intravenous Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Human Immunoglobulin for Intravenous Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immunoglobulin for Intravenous Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immunoglobulin for Intravenous Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Immunoglobulin for Intravenous Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Immunoglobulin for Intravenous Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Immunoglobulin for Intravenous Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Immunoglobulin for Intravenous Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Immunoglobulin for Intravenous Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Immunoglobulin for Intravenous Injection include Zhenghua Shenghua, Zhongyuan Ruide, Weiguang Biological, Tiantan Biological, Taibang Biological, Yuanda shuyang, Shanghai Laishi, Kangbao Biological and Nanyue Biological, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Immunoglobulin for Intravenous Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Immunoglobulin for Intravenous Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Human Immunoglobulin for Intravenous Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Immunoglobulin for Intravenous Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Immunoglobulin for Intravenous Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Immunoglobulin for Intravenous Injection sales, projected growth trends, production technology, application and end-user industry.

Human Immunoglobulin for Intravenous Injection Segment by Company

Zhenghua Shenghua

Zhongyuan Ruide

Weiguang Biological

Tiantan Biological

Taibang Biological

Yuanda shuyang

Shanghai Laishi

Kangbao Biological

Nanyue Biological

Lvshizi

Hualan Biological

Paisi feike

Boya Biological

Human Immunoglobulin for Intravenous Injection Segment by Type

Children

Adult

Human Immunoglobulin for Intravenous Injection Segment by Application

Treatment

Diagnosis

Disease Prevention

Other

Human Immunoglobulin for Intravenous Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunoglobulin for Intravenous Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immunoglobulin for Intravenous Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunoglobulin for Intravenous Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Immunoglobulin for Intravenous Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Immunoglobulin for Intravenous Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Immunoglobulin for Intravenous Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Immunoglobulin for Intravenous Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Children Major Manufacturers Table 3. Adult Major Manufacturers Table 4. Global Human Immunoglobulin for Intravenous Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Treatment Major Manufacturers Table 6. Diagnosis Major Manufacturers Table 7. Disease Prevention Major Manufacturers Table 8. Other Major Manufacturers Table 9. Human Immunoglobulin for Intravenous Injection Industry Trends Table 10. Human Immunoglobulin for Intravenous Injection Industry Drivers Table 11. Human Immunoglobulin for Intravenous Injection Industry Opportunities and Challenges Table 12. Human Immunoglobulin for Intravenous Injection Industry Restraints Table 13. Global Human Immunoglobulin for Intravenous Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Human Immunoglobulin for Intravenous Injection Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Human Immunoglobulin for Intravenous Injection Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2021-2026) Table 17. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2027-2032) Table 18. Global Human Immunoglobulin for Intravenous Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Human Immunoglobulin for Intravenous Injection Sales by Region (2021-2026) & (K Units) Table 20. Global Human Immunoglobulin for Intravenous Injection Sales by Region (2027-2032) & (K Units) Table 21. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2021-2026) Table 22. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2027-2032) Table 23. Global Human Immunoglobulin for Intravenous Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Human Immunoglobulin for Intravenous Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Manufacturers (2021-2026) Table 27. Global Human Immunoglobulin for Intravenous Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Human Immunoglobulin for Intravenous Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Human Immunoglobulin for Intravenous Injection Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Human Immunoglobulin for Intravenous Injection Manufacturers, Product Type & Application Table 31. Global Human Immunoglobulin for Intravenous Injection Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Human Immunoglobulin for Intravenous Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Human Immunoglobulin for Intravenous Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2021-2026) Table 38. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2027-2032) Table 39. Global Human Immunoglobulin for Intravenous Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2026) & (K Units) Table 41. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2027-2032) & (K Units) Table 42. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2021-2026) Table 43. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2027-2032) Table 44. Global Human Immunoglobulin for Intravenous Injection Price by Type (2021-2026) & (US$/Unit) Table 45. Global Human Immunoglobulin for Intravenous Injection Price by Type (2027-2032) & (US$/Unit) Table 46. Global Human Immunoglobulin for Intravenous Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2021-2026) Table 50. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2027-2032) Table 51. Global Human Immunoglobulin for Intravenous Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2027-2032) & (K Units) Table 54. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2021-2026) Table 55. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2027-2032) Table 56. Global Human Immunoglobulin for Intravenous Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Human Immunoglobulin for Intravenous Injection Price by Application (2027-2032) & (US$/Unit) Table 58. Zhenghua Shenghua Company Information Table 59. Zhenghua Shenghua Business Overview Table 60. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Portfolio Table 62. Zhenghua Shenghua Recent Development Table 63. Zhongyuan Ruide Company Information Table 64. Zhongyuan Ruide Business Overview Table 65. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Portfolio Table 67. Zhongyuan Ruide Recent Development Table 68. Weiguang Biological Company Information Table 69. Weiguang Biological Business Overview Table 70. Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 72. Weiguang Biological Recent Development Table 73. Tiantan Biological Company Information Table 74. Tiantan Biological Business Overview Table 75. Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 77. Tiantan Biological Recent Development Table 78. Taibang Biological Company Information Table 79. Taibang Biological Business Overview Table 80. Taibang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Taibang Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 82. Taibang Biological Recent Development Table 83. Yuanda shuyang Company Information Table 84. Yuanda shuyang Business Overview Table 85. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Portfolio Table 87. Yuanda shuyang Recent Development Table 88. Shanghai Laishi Company Information Table 89. Shanghai Laishi Business Overview Table 90. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Portfolio Table 92. Shanghai Laishi Recent Development Table 93. Kangbao Biological Company Information Table 94. Kangbao Biological Business Overview Table 95. Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 97. Kangbao Biological Recent Development Table 98. Nanyue Biological Company Information Table 99. Nanyue Biological Business Overview Table 100. Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 102. Nanyue Biological Recent Development Table 103. Lvshizi Company Information Table 104. Lvshizi Business Overview Table 105. Lvshizi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lvshizi Human Immunoglobulin for Intravenous Injection Product Portfolio Table 107. Lvshizi Recent Development Table 108. Hualan Biological Company Information Table 109. Hualan Biological Business Overview Table 110. Hualan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hualan Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 112. Hualan Biological Recent Development Table 113. Paisi feike Company Information Table 114. Paisi feike Business Overview Table 115. Paisi feike Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Paisi feike Human Immunoglobulin for Intravenous Injection Product Portfolio Table 117. Paisi feike Recent Development Table 118. Boya Biological Company Information Table 119. Boya Biological Business Overview Table 120. Boya Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Boya Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 122. Boya Biological Recent Development Table 123. North America Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Human Immunoglobulin for Intravenous Injection Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2026) & (K Units) Table 126. North America Human Immunoglobulin for Intravenous Injection Sales by Type (2027-2032) & (K Units) Table 127. North America Human Immunoglobulin for Intravenous Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 128. North America Human Immunoglobulin for Intravenous Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 129. North America Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Human Immunoglobulin for Intravenous Injection Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2026) & (K Units) Table 132. North America Human Immunoglobulin for Intravenous Injection Sales by Application (2027-2032) & (K Units) Table 133. North America Human Immunoglobulin for Intravenous Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 134. North America Human Immunoglobulin for Intravenous Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 135. North America Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 139. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 140. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 141. North America Human Immunoglobulin for Intravenous Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 142. North America Human Immunoglobulin for Intravenous Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 143. United States Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 144. Canada Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 145. Europe Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Human Immunoglobulin for Intravenous Injection Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2026) & (K Units) Table 148. Europe Human Immunoglobulin for Intravenous Injection Sales by Type (2027-2032) & (K Units) Table 149. Europe Human Immunoglobulin for Intravenous Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 150. Europe Human Immunoglobulin for Intravenous Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 151. Europe Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Human Immunoglobulin for Intravenous Injection Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2026) & (K Units) Table 154. Europe Human Immunoglobulin for Intravenous Injection Sales by Application (2027-2032) & (K Units) Table 155. Europe Human Immunoglobulin for Intravenous Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 156. Europe Human Immunoglobulin for Intravenous Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Europe Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 161. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 162. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 163. Europe Human Immunoglobulin for Intravenous Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 164. Europe Human Immunoglobulin for Intravenous Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 165. Germany Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 166. France Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 167. U.K. Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 168. Italy Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 169. Netherlands Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 170. China Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2026) & (US$ Million) Table 171. China Human Immunoglobulin for Intravenous Injection Revenue by Type (2027-2032) & (US$ Million) Table 172. China Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2026) & (K Units) Table 173. China Human Immunoglobulin for Intravenous Injection Sales by Type (2027-2032) & (K Units) Table 174. China Human Immunoglobulin for Intravenous Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Human Immunoglobulin for Intravenous Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2026) & (US$ Million) Table 177. China Human Immunoglobulin for Intravenous Injection Revenue by Application (2027-2032) & (US$ Million) Table 178. China Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2026) & (K Units) Table 179. China Human Immunoglobulin for Intravenous Injection Sales by Application (2027-2032) & (K Units) Table 180. China Human Immunoglobulin for Intravenous Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Human Immunoglobulin for Intravenous Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Human Immunoglobulin for Intravenous Injection Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2026) & (K Units) Table 185. Asia Human Immunoglobulin for Intravenous Injection Sales by Type (2027-2032) & (K Units) Table 186. Asia Human Immunoglobulin for Intravenous Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Human Immunoglobulin for Intravenous Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Human Immunoglobulin for Intravenous Injection Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2026) & (K Units) Table 191. Asia Human Immunoglobulin for Intravenous Injection Sales by Application (2027-2032) & (K Units) Table 192. Asia Human Immunoglobulin for Intravenous Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Human Immunoglobulin for Intravenous Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Human Immunoglobulin for Intravenous Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Asia Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 199. Asia Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 200. Asia Human Immunoglobulin for Intravenous Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Human Immunoglobulin for Intravenous Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 203. South Korea Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 204. India Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 205. Australia Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 206. China Taiwan Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Human Immunoglobulin for Intravenous Injection Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2026) & (K Units) Table 211. SAMEA Human Immunoglobulin for Intravenous Injection Sales by Type (2027-2032) & (K Units) Table 212. SAMEA Human Immunoglobulin for Intravenous Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Human Immunoglobulin for Intravenous Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Human Immunoglobulin for Intravenous Injection Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2026) & (K Units) Table 217. SAMEA Human Immunoglobulin for Intravenous Injection Sales by Application (2027-2032) & (K Units) Table 218. SAMEA Human Immunoglobulin for Intravenous Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Human Immunoglobulin for Intravenous Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Human Immunoglobulin for Intravenous Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. SAMEA Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 225. SAMEA Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 226. SAMEA Human Immunoglobulin for Intravenous Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Human Immunoglobulin for Intravenous Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 229. Argentina Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 230. Chile Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 231. Colombia Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 232. Peru Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 234. Israel Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 235. UAE Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 236. Turkey Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 237. Iran Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 238. Egypt Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Human Immunoglobulin for Intravenous Injection Distributors List Table 242. Human Immunoglobulin for Intravenous Injection Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Human Immunoglobulin for Intravenous Injection Image Figure 2. Global Human Immunoglobulin for Intravenous Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Immunoglobulin for Intravenous Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Children Image Figure 5. Adult Image Figure 6. Global Human Immunoglobulin for Intravenous Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Immunoglobulin for Intravenous Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Treatment Image Figure 9. Diagnosis Image Figure 10. Disease Prevention Image Figure 11. Other Image Figure 12. Global Human Immunoglobulin for Intravenous Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Immunoglobulin for Intravenous Injection Revenue (2021-2032) & (US$ Million) Figure 14. Global Human Immunoglobulin for Intravenous Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2021-2032) Figure 17. Global Human Immunoglobulin for Intravenous Injection Sales (2021-2032) & (K Units) Figure 18. Global Human Immunoglobulin for Intravenous Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Human Immunoglobulin for Intravenous Injection Sales YoY (2021-2032) & (K Units) Figure 21. Europe Human Immunoglobulin for Intravenous Injection Sales YoY (2021-2032) & (K Units) Figure 22. China Human Immunoglobulin for Intravenous Injection Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Human Immunoglobulin for Intravenous Injection Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales YoY (2021-2032) & (K Units) Figure 25. Global Human Immunoglobulin for Intravenous Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Human Immunoglobulin for Intravenous Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2021-2032) Figure 31. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2021-2032) Figure 34. Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2021-2032) Figure 37. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2021-2032) Figure 40. North America Human Immunoglobulin for Intravenous Injection Revenue Share by Type (2021-2032) Figure 41. North America Human Immunoglobulin for Intravenous Injection Sales Share by Type (2021-2032) Figure 42. North America Human Immunoglobulin for Intravenous Injection Revenue Share by Application (2021-2032) Figure 43. North America Human Immunoglobulin for Intravenous Injection Sales Share by Application (2021-2032) Figure 44. North America Human Immunoglobulin for Intravenous Injection Revenue Share by Country (2021-2032) Figure 45. North America Human Immunoglobulin for Intravenous Injection Sales Share by Country (2021-2032) Figure 46. Europe Human Immunoglobulin for Intravenous Injection Revenue Share by Type (2021-2032) Figure 47. Europe Human Immunoglobulin for Intravenous Injection Sales Share by Type (2021-2032) Figure 48. Europe Human Immunoglobulin for Intravenous Injection Revenue Share by Application (2021-2032) Figure 49. Europe Human Immunoglobulin for Intravenous Injection Sales Share by Application (2021-2032) Figure 50. Europe Human Immunoglobulin for Intravenous Injection Revenue Share by Country (2021-2032) Figure 51. Europe Human Immunoglobulin for Intravenous Injection Sales Share by Country (2021-2032) Figure 52. China Human Immunoglobulin for Intravenous Injection Revenue Share by Type (2021-2032) Figure 53. China Human Immunoglobulin for Intravenous Injection Sales Share by Type (2021-2032) Figure 54. China Human Immunoglobulin for Intravenous Injection Revenue Share by Application (2021-2032) Figure 55. China Human Immunoglobulin for Intravenous Injection Sales Share by Application (2021-2032) Figure 56. Asia Human Immunoglobulin for Intravenous Injection Revenue Share by Type (2021-2032) Figure 57. Asia Human Immunoglobulin for Intravenous Injection Sales Share by Type (2021-2032) Figure 58. Asia Human Immunoglobulin for Intravenous Injection Revenue Share by Application (2021-2032) Figure 59. Asia Human Immunoglobulin for Intravenous Injection Sales Share by Application (2021-2032) Figure 60. Asia Human Immunoglobulin for Intravenous Injection Revenue Share by Country (2021-2032) Figure 61. Asia Human Immunoglobulin for Intravenous Injection Sales Share by Country (2021-2032) Figure 62. SAMEA Human Immunoglobulin for Intravenous Injection Revenue Share by Type (2021-2032) Figure 63. SAMEA Human Immunoglobulin for Intravenous Injection Sales Share by Type (2021-2032) Figure 64. SAMEA Human Immunoglobulin for Intravenous Injection Revenue Share by Application (2021-2032) Figure 65. SAMEA Human Immunoglobulin for Intravenous Injection Sales Share by Application (2021-2032) Figure 66. SAMEA Human Immunoglobulin for Intravenous Injection Revenue Share by Country (2021-2032) Figure 67. SAMEA Human Immunoglobulin for Intravenous Injection Sales Share by Country (2021-2032) Figure 68. Human Immunoglobulin for Intravenous Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Human Immunoglobulin for Intravenous Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 7

Scope & coverage.

Types
  • Children
  • Adult
Applications
  • Treatment
  • Diagnosis
  • Disease Prevention
  • Other
Companies covered
  • Zhenghua Shenghua
  • Zhongyuan Ruide
  • Weiguang Biological
  • Tiantan Biological
  • Taibang Biological
  • Yuanda shuyang
  • Shanghai Laishi
  • Kangbao Biological
  • Nanyue Biological
  • Lvshizi
  • Hualan Biological
  • Paisi feike
  • Boya Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Immunoglobulin for Intravenous Injection Market by Type
  3. 1.2.1 Global Human Immunoglobulin for Intravenous Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Children
  5. 1.2.3 Adult
  6. 1.3 Human Immunoglobulin for Intravenous Injection Market by Application
  7. 1.3.1 Global Human Immunoglobulin for Intravenous Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Treatment
  9. 1.3.3 Diagnosis
  10. 1.3.4 Disease Prevention
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Immunoglobulin for Intravenous Injection Market Dynamics
  1. 2.1 Human Immunoglobulin for Intravenous Injection Industry Trends
  2. 2.2 Human Immunoglobulin for Intravenous Injection Industry Drivers
  3. 2.3 Human Immunoglobulin for Intravenous Injection Industry Opportunities and Challenges
  4. 2.4 Human Immunoglobulin for Intravenous Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Immunoglobulin for Intravenous Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Immunoglobulin for Intravenous Injection Revenue by Region
  3. 3.2.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Immunoglobulin for Intravenous Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Immunoglobulin for Intravenous Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Immunoglobulin for Intravenous Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Immunoglobulin for Intravenous Injection Sales by Region
  9. 3.4.1 Global Human Immunoglobulin for Intravenous Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Immunoglobulin for Intravenous Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Human Immunoglobulin for Intravenous Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Manufacturers
  2. 4.1.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Immunoglobulin for Intravenous Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Immunoglobulin for Intravenous Injection Sales by Manufacturers
  6. 4.2.1 Global Human Immunoglobulin for Intravenous Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Immunoglobulin for Intravenous Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Immunoglobulin for Intravenous Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Immunoglobulin for Intravenous Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Immunoglobulin for Intravenous Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Immunoglobulin for Intravenous Injection Manufacturers, Product Type & Application
  13. 4.7 Global Human Immunoglobulin for Intravenous Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Immunoglobulin for Intravenous Injection Market CR5 and HHI
  16. 4.8.2 2025 Human Immunoglobulin for Intravenous Injection Tier 1, Tier 2, and Tier 3
5 Human Immunoglobulin for Intravenous Injection Market by Type
  1. 5.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Type
  2. 5.1.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Immunoglobulin for Intravenous Injection Sales by Type
  6. 5.2.1 Global Human Immunoglobulin for Intravenous Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Immunoglobulin for Intravenous Injection Price by Type
6 Human Immunoglobulin for Intravenous Injection Market by Application
  1. 6.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Application
  2. 6.1.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Immunoglobulin for Intravenous Injection Sales by Application
  6. 6.2.1 Global Human Immunoglobulin for Intravenous Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Immunoglobulin for Intravenous Injection Price by Application
7 Company Profiles
  1. 7.1 Zhenghua Shenghua
  2. 7.1.1 Zhenghua Shenghua Company Information
  3. 7.1.2 Zhenghua Shenghua Business Overview
  4. 7.1.3 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Portfolio
  6. 7.1.5 Zhenghua Shenghua Recent Developments
  7. 7.2 Zhongyuan Ruide
  8. 7.2.1 Zhongyuan Ruide Company Information
  9. 7.2.2 Zhongyuan Ruide Business Overview
  10. 7.2.3 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Portfolio
  12. 7.2.5 Zhongyuan Ruide Recent Developments
  13. 7.3 Weiguang Biological
  14. 7.3.1 Weiguang Biological Company Information
  15. 7.3.2 Weiguang Biological Business Overview
  16. 7.3.3 Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  18. 7.3.5 Weiguang Biological Recent Developments
  19. 7.4 Tiantan Biological
  20. 7.4.1 Tiantan Biological Company Information
  21. 7.4.2 Tiantan Biological Business Overview
  22. 7.4.3 Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  24. 7.4.5 Tiantan Biological Recent Developments
  25. 7.5 Taibang Biological
  26. 7.5.1 Taibang Biological Company Information
  27. 7.5.2 Taibang Biological Business Overview
  28. 7.5.3 Taibang Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Taibang Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  30. 7.5.5 Taibang Biological Recent Developments
  31. 7.6 Yuanda shuyang
  32. 7.6.1 Yuanda shuyang Company Information
  33. 7.6.2 Yuanda shuyang Business Overview
  34. 7.6.3 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Portfolio
  36. 7.6.5 Yuanda shuyang Recent Developments
  37. 7.7 Shanghai Laishi
  38. 7.7.1 Shanghai Laishi Company Information
  39. 7.7.2 Shanghai Laishi Business Overview
  40. 7.7.3 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Portfolio
  42. 7.7.5 Shanghai Laishi Recent Developments
  43. 7.8 Kangbao Biological
  44. 7.8.1 Kangbao Biological Company Information
  45. 7.8.2 Kangbao Biological Business Overview
  46. 7.8.3 Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  48. 7.8.5 Kangbao Biological Recent Developments
  49. 7.9 Nanyue Biological
  50. 7.9.1 Nanyue Biological Company Information
  51. 7.9.2 Nanyue Biological Business Overview
  52. 7.9.3 Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  54. 7.9.5 Nanyue Biological Recent Developments
  55. 7.10 Lvshizi
  56. 7.10.1 Lvshizi Company Information
  57. 7.10.2 Lvshizi Business Overview
  58. 7.10.3 Lvshizi Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lvshizi Human Immunoglobulin for Intravenous Injection Product Portfolio
  60. 7.10.5 Lvshizi Recent Developments
  61. 7.11 Hualan Biological
  62. 7.11.1 Hualan Biological Company Information
  63. 7.11.2 Hualan Biological Business Overview
  64. 7.11.3 Hualan Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hualan Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  66. 7.11.5 Hualan Biological Recent Developments
  67. 7.12 Paisi feike
  68. 7.12.1 Paisi feike Company Information
  69. 7.12.2 Paisi feike Business Overview
  70. 7.12.3 Paisi feike Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Paisi feike Human Immunoglobulin for Intravenous Injection Product Portfolio
  72. 7.12.5 Paisi feike Recent Developments
  73. 7.13 Boya Biological
  74. 7.13.1 Boya Biological Company Information
  75. 7.13.2 Boya Biological Business Overview
  76. 7.13.3 Boya Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Boya Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  78. 7.13.5 Boya Biological Recent Developments
8 North America
  1. 8.1 North America Human Immunoglobulin for Intravenous Injection Market Size by Type
  2. 8.1.1 North America Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Human Immunoglobulin for Intravenous Injection Price by Type (2021-2032)
  5. 8.2 North America Human Immunoglobulin for Intravenous Injection Market Size by Application
  6. 8.2.1 North America Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Human Immunoglobulin for Intravenous Injection Price by Application (2021-2032)
  9. 8.3 North America Human Immunoglobulin for Intravenous Injection Market Size by Country
  10. 8.3.1 North America Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Immunoglobulin for Intravenous Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Immunoglobulin for Intravenous Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Human Immunoglobulin for Intravenous Injection Market Size by Type
  2. 9.1.1 Europe Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Immunoglobulin for Intravenous Injection Price by Type (2021-2032)
  5. 9.2 Europe Human Immunoglobulin for Intravenous Injection Market Size by Application
  6. 9.2.1 Europe Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Immunoglobulin for Intravenous Injection Price by Application (2021-2032)
  9. 9.3 Europe Human Immunoglobulin for Intravenous Injection Market Size by Country
  10. 9.3.1 Europe Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Immunoglobulin for Intravenous Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Human Immunoglobulin for Intravenous Injection Market Size by Type
  2. 10.1.1 China Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032)
  4. 10.1.3 China Human Immunoglobulin for Intravenous Injection Price by Type (2021-2032)
  5. 10.2 China Human Immunoglobulin for Intravenous Injection Market Size by Application
  6. 10.2.1 China Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032)
  8. 10.2.3 China Human Immunoglobulin for Intravenous Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Immunoglobulin for Intravenous Injection Market Size by Type
  2. 11.1.1 Asia Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Immunoglobulin for Intravenous Injection Price by Type (2021-2032)
  5. 11.2 Asia Human Immunoglobulin for Intravenous Injection Market Size by Application
  6. 11.2.1 Asia Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Immunoglobulin for Intravenous Injection Price by Application (2021-2032)
  9. 11.3 Asia Human Immunoglobulin for Intravenous Injection Market Size by Country
  10. 11.3.1 Asia Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Immunoglobulin for Intravenous Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Immunoglobulin for Intravenous Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Immunoglobulin for Intravenous Injection Market Size by Type
  2. 12.1.1 SAMEA Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Immunoglobulin for Intravenous Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Human Immunoglobulin for Intravenous Injection Market Size by Application
  6. 12.2.1 SAMEA Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Immunoglobulin for Intravenous Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Human Immunoglobulin for Intravenous Injection Market Size by Country
  10. 12.3.1 SAMEA Human Immunoglobulin for Intravenous Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Immunoglobulin for Intravenous Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Immunoglobulin for Intravenous Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Immunoglobulin for Intravenous Injection Value Chain Analysis
  2. 13.1.1 Human Immunoglobulin for Intravenous Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Immunoglobulin for Intravenous Injection Production Mode & Process
  6. 13.2 Human Immunoglobulin for Intravenous Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Immunoglobulin for Intravenous Injection Distributors
  9. 13.2.3 Human Immunoglobulin for Intravenous Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst